The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
Zeng Ye1, Qiang Li2, Yuheng Hu1
1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Center for Neuroendocrine Tumors, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Shanghai Pancreatic Cancer Institute, Shanghai, 200032, China; Pancreatic Cancer Institute, Fudan University, Shanghai, 200032, China.
View abstract on PubMed
Cancer-associated fibroblasts (CAFs) drive tumor growth and metastasis in pancreatic neuroendocrine tumors. Myofibroblastic CAFs promote epithelial-mesenchymal transition (EMT) and liver metastasis through TGF-β signaling.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Cancer-associated fibroblasts (CAFs) are crucial in various cancers, but their role in nonfunctional pancreatic neuroendocrine tumors (NF-PanNETs) is understudied.
- Tumor stroma heterogeneity can influence malignant phenotypes in NF-PanNETs.
Purpose of the Study:
- To investigate the role of CAF heterogeneity in NF-PanNETs.
- To elucidate the mechanisms by which CAFs contribute to tumor growth and metastasis in NF-PanNETs.
Main Methods:
- Analysis of stromal proportion and growth patterns in NF-PanNET patient samples.
- Spatial profiling of myofibroblastic CAFs (myCAFs) and their proximity to tumor cells.
- Investigation of TGF-β signaling pathways involved in epithelial-mesenchymal transition (EMT).


